ACOR insider filings
Acorda Therapeutics, Inc. — 9 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-23. Screen ACOR transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ACOR between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Acorda Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-06-23 | 4 | BURNS THOMAS M. — Director | Grant/award (A): 2,400 (derivative) @ $0 | EDGAR |
| 2023-06-23 | 4 | Varian John — Director | Grant/award (A): 1,200 (derivative) @ $0 | EDGAR |
| 2023-06-23 | 4 | PANEM SANDRA PHD — Director | Grant/award (A): 1,200 (derivative) @ $0 | EDGAR |
| 2023-06-23 | 4 | Kelley John P — Director | Grant/award (A): 1,200 (derivative) @ $0 | EDGAR |
| 2023-06-23 | 4 | Jensen Peder — Director | Grant/award (A): 1,200 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | COHEN RON — President and CEO, Director | Grant/award (A): 168,800 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Clem Kerry M — Chief Commercial Officer | Grant/award (A): 77,300 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Belloff Neil S. — General Counsel and Corp Secy | Grant/award (A): 77,300 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | COHEN RON — President and CEO, Director | Purchase (P): 10,156 @ $0.60 · Purchase (P): 10,000 @ $0.65 | EDGAR |
Recent 8-K events — Acorda Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-08-09 | 8-K | 1.03 — Bankruptcy or Receivership 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-07-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-07-11 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-25 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-06-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-05-24 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-26 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-04-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-04 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ACOR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →